RVMDW 8-K 2026-09-01

Revolution Medicines, Inc. (RVMDW) 8-K dated 2026-09-01 — accession 0001193125-26-377362.

Revolution Medicines, Inc. (RVMDW) warrant listed on NASDAQ.

Revolution Medicines, Inc. filed a 8-K on 2026-09-01. Accession 0001193125-26-377362.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03). SEC EDGAR holds the official filing and its exhibits.

Latest reported RVMDW revenue for 2025-12-31 was $0. Net income was -$1.13B. RVMDW currently screens at market cap $1.88B.

Not investment advice. The RVMDW SEC hub lists recent forms. The stock page is the research view.